Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LACTB is a serine beta-lactamase-like protein localized in the mitochondrial intermembrane space. It regulates mitochondrial lipid metabolism and functions as a tumor suppressor. Overexpression is linked to obesity phenotypes, and it plays a role in cancer by modulating lipid metabolism, interacting with p53, and influencing responses to chemotherapy. It also contributes to mitochondrial organization through filament formation.
Acts as an active-site serine protease regulating mitochondrial lipid metabolism; Directly binds to p53’s C-terminal region, preventing its degradation; Modulates responses to chemotherapeutic agents such as oxaliplatin by decreasing glucose uptake/ATP synthesis, inducing DNA damage, inhibiting autophagy, promoting apoptosis via caspase-independent pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine beta-lactamase-like protein LACTB, mitochondrial.